Clinical Use of Ultrasensitive Cardiac Troponin I Assay in Intermediate- and High-Risk Surgery Patients

<table>Primary event-free survival (a) and overall survival (b) stratified by postoperative cardiac troponin I (cTnI) peak levels less than or greater than 0.04 <i>μ</i>g/L during the 30-day postoperative follow-up period.</table>

Disease Markers

fig1

Figure 1

Figure 1: Clinical Use of Ultrasensitive Cardiac Troponin I Assay in Intermediate- and High-Risk Surgery Patients 